Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3

Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3

Background: Epimers of ginsenoside Rg3 (Rg3) have a low bioavailability and are prone to deglycosylation, which produces epimers of ginsenoside Rh2 (S–Rh2 and R–Rh2) and protopanaxadiol (S-PPD and R-PPD). The aim of this study was to compare the efficacy and potency of these molecules as anti-cancer...

Full description

Bibliographic Details
Main Authors: Maryam Nakhjavani, Eric Smith, Kenny Yeo, Yoko Tomita, Timothy J. Price, Andrea Yool, Amanda R. Townsend, Jennifer E. Hardingham
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Ginseng Research
Subjects:
Anticancer
Epimer
Ginsenoside Rh2
Ginsenoside Rg3
Protopanaxadiol
Online Access:http://www.sciencedirect.com/science/article/pii/S1226845321000750

Internet

http://www.sciencedirect.com/science/article/pii/S1226845321000750

Similar Items